Trial intelligence / Profile preview

Secretin for BAT Activation and Satiation

NCT03290846Phase 3Completed

Sponsor
Turku University Hospital
Start
Aug 2016
Primary completion
Oct 2019
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of secretin in obesity, sponsored by Turku University Hospital. Started Aug 2016; status: completed.

02

Drugs

secretin
03

Conditions

obesity

Beyond the preview

Go deeper on NCT03290846.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03290846.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call